Novavax
NVAX
#5101
Rank
A$2.59 B
Marketcap
A$15.72
Share price
1.02%
Change (1 day)
43.71%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -A$0.34 Billion

According to Novavax's latest financial reports the company's current earnings are A$0.41 Billion. In 2025 the company made an earning of A$0.67 Billion, an increase over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.34 Billion-149.95%
2025 A$0.67 B-396.87%
2024 -A$0.23 Billion-70.39%
2023 -A$0.77 Billion-16.59%
2022 -A$0.92 Billion-62.58%
2021 -A$2.45 Billion320.54%
2020 -A$0.59 Billion234.22%
2019 -A$0.18 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.25 Billion-36.44%
2016 -A$0.39 Billion70.4%
2015 -A$0.23 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$74.8 Million81.9%
2012 -A$41.12 Million50.33%
2011 -A$27.36 Million
2009 -A$53.98 Million8.8%
2008 -A$49.62 Million18.01%
2007 -A$42.05 Million18.33%
2006 -A$35.54 Million168.31%
2005 -A$13.25 Million-62.51%
2004 -A$35.33 Million52.4%
2003 -A$23.18 Million-28.21%
2002 -A$32.29 Million
2000 -A$18.4 Million177%
1999 -A$6.65 Million-11.54%
1998 -A$7.51 Million10.64%
1997 -A$6.79 Million-9.62%
1996 -A$7.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$18.25 B-5,758.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.97 B-3,191.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.69 B-6,514.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$10.33 B-3,302.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.19 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.48 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.21 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.69 Million-96.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.56 Billion 70.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA